Panelists included Stephen Zamierowski of Deloitte Services LLP, Paul D. Broude of Foley, and Les Cheek of Robert W. Baird & Co. The program addresses the substantive value that an experienced board provides to both start-up companies and companies looking to exit. During the merger and acquisition (M&A) process, an experienced board can assess available financing options and provide guidance based on the transaction, whether it involves going public, selling, or an interim step like a joint venture.
Related Insights
21 October 2024
Events
Legal Overview of the BIOSECURE Act
Foley special counsel John Strom is speaking in the Association for Accessible Medicine’s GRx+Biosims 2024 conference in a panel titled “Legal Overview of the BIOSECURE Act” on October 21.
04 October 2024
Innovative Technology Insights
Decoding California’s Recent Flurry of AI Laws
Governor Newsom signed over 18 AI-related bills into law during September, impacting numerous industries.
17 October 2024
Events
Top Compliance Considerations when Commercializing in the U.S.
Kyle Faget and Nathan "Nate" Beaver, co-chair of Foley's Medical Device and Equipment Area of Focus within the firm's Health Care & Life Sciences Sector, invite you to join us for a webinar on the compliance considerations you need to know when you are commercializing your medical device products in the U.S.